A Phase 2 interventional study of PLAN CUIDARTE and Conventional care in Heart Failure, Caregiver Burden and Discharge Plan, sponsored by Universidad de la Sabana. Not yet recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-13.
Sponsored by Universidad de la Sabana · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Heart Failure with a site in Colombia — 7 open to participants now, 9 under way, 5 of them phase 3. Heart Failure · Colombia.
Among the 39 studies in Heart Failure with a site in Colombia, this one is the 30th largest by planned enrollment of the 34 interventional ones that give a count, is one of 3 that started in 2024, is one of 2 in phase 2, and was the 34th registered.
6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.
Browse Heart Failure studies →7 of the 39 studies in Heart Failure with a site in Colombia are open now. Recruiting first, the newest first:
Amgen · Sites in Colombia, United States, Argentina and 32 more countries
Ages 18–99
Boehringer Ingelheim · Sites in Colombia, United States, Argentina and 26 more countries
Ages 18+
Boehringer Ingelheim · Sites in Colombia, United States, Argentina and 27 more countries
Ages 18+
Merck Sharp & Dohme LLC · Sites in Colombia, United States, Belgium and 27 more countries
Ages 29 days–17 yrs
Clinica Cardio VID · Sites in Colombia
Ages 18+
A study can be open while its sites in Colombia have not opened yet or have stopped. Only those recruiting at a site in Colombia →
Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 21 · Phase 4 1
First in 2003; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 84 is above the median of 76 across 4,053 interventional studies indexed under Heart Failure.
Median enrollment 3,388 across the 34 interventional studies, 2,169 across the 5 observational. Of the 27 that completed or were terminated, 20 (74%) have results posted.
This tab as a report to print or save as PDF → With an account.
29 of 39 have an industry lead sponsor. The 10 most frequent:
Universidad de la Sabana is the lead sponsor of 23 studies on the registry; 8 are open to participants now.
Universidad de la Sabana has 2 studies filed under Heart Failure — fewer than ten, so there is no comparison to draw.
3 of the studies in Heart Failure with a site in Colombia that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06307652Phase 3AstraZenecaStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function | 2027-04-16 |
| NCT07478081Universidad de la SabanamHealth Intervention to Support Self-care During the Hospital to Home Transition in Individuals With Heart Failure | 2027-06 |
| NCT07664189Clinica Cardio VIDLBBP + CSP Versus LBBP Alone for Cardiac Resynchronization Therapy | 2027-07-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 39 studies in Heart Failure with a site in Colombia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
According to the World Health Organization (WHO), by 2021 cardiovascular diseases (CVD) will be a public health problem, among them heart failure (HF), since this is a chronic disease, patients should be competent in their care. Despite the above, according to research conducted in Colombia, 59.7% of people with chronic noncommunicable diseases (NCDs) have a level of care competence considered not optimal; patients report not having sufficient knowledge of the disease or experience feelings of lack of tools for the management of symptoms and the challenges of post-hospitalization.
The objective of the research is to determine the effect of the PLAN CUIDARTE on the caregiving competence of people with HF
Methodology: Pre-posttest randomized clinical trial, with blinding of the participants, where the intervention "PLAN CUIDARTE" is applied and the initial and subsequent caregiving competence is evaluated in the comparison group and in the intervention group for pretest - posttest and between-group comparisons.
Eligibility Criteria:
Inclusion criteria
Exclusion criteria
Outcome Measures:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Set of specific activities carried out by the health care team by the health care team at the time of hospital discharge of HF patients: the patients with HF:
Other: Conventional care
The "PLAN CUIDARTE" is an intervention aimed at addressing the hospital discharge of people with HF, based on the nursing theory of transitions of Afaf Meleis(46) and under the guidelines of Robin Whittemore for the systematic development of complex interventions for experimental type research in nursing. The PLAN CUIDARTE addresses the specific educational needs of HF patients, as established by the patients with HF, as established by international accreditation standards.
Other: PLAN CUIDARTE
Description Plan Cuidarte
Description Conventional care
Care Competence
capacity, ability and preparation of the patient or family caregiver to the patient or family caregiver to perform the task of caregiving(4), which is made up of the following five dimensions: knowledge five dimensions: knowledge, uniqueness, instrumental, enjoyment, anticipation and social relationship, uniqueness, instrumental, enjoyment, anticipation and social relationship.
Time frame: 30 days
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Mar 2024; primary completion for Jun 2024, 3 months later.
Of 111 non-industry phase 2 interventional studies under Heart Failure, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 66. This study's planned 3 months is below that.
Counting every sponsor, half of 185 studies reached it within 29 months; a quarter within 17 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de la Sabana